Fusion Pharmaceuticals Statistics
Total Valuation
FUSN has a market cap or net worth of $1.82 billion. The enterprise value is $1.63 billion.
| Market Cap | 1.82B |
| Enterprise Value | 1.63B |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FUSN has 84.87 million shares outstanding. The number of shares has increased by 49.98% in one year.
| Shares Outstanding | 84.87M |
| Shares Change (YoY) | +49.98% |
| Shares Change (QoQ) | +5.98% |
| Owned by Insiders (%) | 4.40% |
| Owned by Institutions (%) | 79.10% |
| Float | 63.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 879.02 |
| Forward PS | 2,959.87 |
| PB Ratio | 8.17 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 789.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.01, with a Debt / Equity ratio of 0.23.
| Current Ratio | 15.01 |
| Quick Ratio | 14.48 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.22 |
Financial Efficiency
Return on equity (ROE) is -46.60% and return on invested capital (ROIC) is -36.37%.
| Return on Equity (ROE) | -46.60% |
| Return on Assets (ROA) | -35.30% |
| Return on Capital (ROIC) | -36.37% |
| Revenue Per Employee | $20,475 |
| Profits Per Employee | -$939,574 |
| Employee Count | 101 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FUSN has paid $787,000 in taxes.
| Income Tax | 787,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +462.21% in the last 52 weeks. The beta is -0.72, so FUSN's price volatility has been lower than the market average.
| Beta (1Y) | -0.72 |
| 52-Week Price Change | +462.21% |
| 50-Day Moving Average | 16.25 |
| 200-Day Moving Average | 7.91 |
| Relative Strength Index (RSI) | 80.52 |
| Average Volume (30 Days) | 2,197,532 |
Short Selling Information
The latest short interest is 5.20 million, so 6.13% of the outstanding shares have been sold short.
| Short Interest | 5.20M |
| Short Previous Month | 7.92M |
| Short % of Shares Out | 6.13% |
| Short % of Float | 8.21% |
| Short Ratio (days to cover) | 1.35 |
Income Statement
In the last 12 months, FUSN had revenue of $2.07 million and -$94.90 million in losses. Loss per share was -$1.45.
| Revenue | 2.07M |
| Gross Profit | 2.07M |
| Operating Income | -99.23M |
| Pretax Income | -94.11M |
| Net Income | -94.90M |
| EBITDA | -85.08M |
| EBIT | -88.94M |
| Loss Per Share | -$1.45 |
Balance Sheet
The company has $234.93 million in cash and $50.33 million in debt, giving a net cash position of $184.60 million or $2.18 per share.
| Cash & Cash Equivalents | 234.93M |
| Total Debt | 50.33M |
| Net Cash | 184.60M |
| Net Cash Per Share | $2.18 |
| Equity / Book Value | 222.48M |
| Book Value Per Share | 2.62 |
| Working Capital | 227.18M |
Cash Flow
In the last 12 months, operating cash flow was -$81.80 million and capital expenditures -$3.89 million, giving a free cash flow of -$85.69 million.
| Operating Cash Flow | -81.80M |
| Capital Expenditures | -3.89M |
| Free Cash Flow | -85.69M |
| FCF Per Share | -$1.31 |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,798.45% and -4,588.83%.
| Gross Margin | 100.00% |
| Operating Margin | -4,798.45% |
| Pretax Margin | -4,550.77% |
| Profit Margin | -4,588.83% |
| EBITDA Margin | -4,114.12% |
| EBIT Margin | -4,300.97% |
| FCF Margin | -4,143.71% |
Dividends & Yields
FUSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.98% |
| Shareholder Yield | -49.98% |
| Earnings Yield | -5.22% |
| FCF Yield | -4.71% |
Analyst Forecast
The average price target for FUSN is $20.86, which is -2.61% lower than the current price. The consensus rating is "Hold".
| Price Target | $20.86 |
| Price Target Difference | -2.61% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 85.16% |
| EPS Growth Forecast (5Y) | -1.03% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FUSN has an Altman Z-Score of 15.3 and a Piotroski F-Score of 3.
| Altman Z-Score | 15.3 |
| Piotroski F-Score | 3 |